losartan

(redirected from losartan potassium)
Also found in: Medical, Acronyms.
Related to losartan potassium: lisinopril

lo·sar·tan

 (lō-sär′tăn)
n.
An angiotensin II receptor blocker drug, C22H23ClN6O, used in the form of its potassium salt to treat hypertension.

[(ch)lo(ro)- + -sartan, angiotensin II receptor blocker suff. (from s(elective) a(ngiotensin) r(ecep)t(or) an(tagonist)).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

losartan

n losartán m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Following several (https://www.ibtimes.com/blood-pressure-medication-recall-2019-expanded-recall-issued-cancer-causing-impurity-2800134) recalls for blood pressure medication over the last few months because of a cancer-causing impurity, (https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/macleods-pharmaceutical-limited-issues-voluntary-nationwide-consumer-level-recall-losartan-potassium) Macleods Pharmaceuticals Limited has issued a recall for 32 lots of Losartan Potassium USP tablets and Losartan Potassium/Hydrochlorothiazide combination tablets for an impurity that could cause cancer.
The Department of Health in Abu Dhabi issued a circular to all health care facilities and practitioners to remove all supplies of Arbitense 50 and 100mg Losartan Potassium tablet from shelves.
M2 PHARMA-May 15, 2019-Vivimed Life Sciences Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP Due to the Detection of Trace Amounts of N-Nitroso-N-methyl-4-aminobutyric acid Impurity
M2 EQUITYBITES-April 29, 2019-Teva Pharmaceuticals USA recalls 35 lots of bulk Losartan Potassium USP Tablets
Tokyo, Japan, Apr 24, 2006 - (JCN) - Banyu Pharmaceutical has obtained additional approval for NU-LOTAN Tablet 25mg/ 50mg (losartan potassium), its proprietary agent for treating hypertension, from the Ministry of Health, Labor and Welfare.
((https://finance.yahoo.com/quote/TEVA?p=TEVA&.tsrc=fin-srch) TEVA ) has issued a voluntary recall of another six lots of losartan potassium tablets because of a cancer-causing impurity.
M2 PHARMA-April 29, 2019-Teva Pharmaceuticals USA recalls 35 lots of bulk Losartan Potassium USP Tablets
Merck and Co Inc's Hyzaar is known generically as Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets, while Merck Research Laboratories' Cozaar is generically called Losartan Potassium Tablets.